Skip to main content icon/video/no-internet

Convention on Biological Diversity (CBD)

The convention on biological diversity (cbd) is an international treaty signed by a coalition of 153 countries at the 1992 United Nations Conference on Environment and Development (UNCED). The convention became officially recognized in December 1993 and has 188 members. The United States is the only country that has signed but not yet ratified the CBD. Based on the principle of sustainable development, the main goals include “the conservation of biodiversity, the sustainable use of its components, and the fair and equitable sharing of the benefits arising from the utilization of genetic resources.” Member countries, adopting a precautionary principle approach, are legally required to create plans for identifying and protecting biodiversity, restoring degraded areas, and preventing possible impacts of the introduction of nonnative species and genetically modified organisms into the environment. The convention also recognizes the importance of public participation and protecting the rights of traditionally marginalized communities most directly affected by environmental threats. To do this, it sets a framework utilizing both economic criteria (based on the market value of environmental resources) and noneconomic factors, such as cultural significance, to determine the value of biodiversity as well as the risks and benefits of economic growth.

The governing body of the CBD is the Conference of Parties (COP). Made up of representatives from all member countries, the COP is responsible for identifying priorities, proposing plans of action, reviewing national proposals, and coordinating with international institutions. It also has the authority to create advisory panels like the Subsidiary Body on Scientific, Technical and Technological Advice (SBSTTA), a group assisting with and assessing the convention's implementation. As of 2006, the COP had eight regular meetings with focuses ranging from protecting marine, forest, and agricultural diversity to examining technological cooperation and intellectual property rights. In 2002, the COP adopted a strategic plan for meeting the three goals of the convention, aiming to achieve a broad reduction in the rate of biodiversity loss by 2010.

In addition, the COP called an extraordinary meeting in 2000 to introduce a supplementary agreement to the CBD, the Cartagena Protocol on Biosafety, which came into force September 2003. By April 2006, 132 countries had ratified the protocol that established rules on the transboundary movement, handling, and use of genetically modified organisms (GMOs). Expressing the mandate of the CBD, member countries are encouraged to adopt a precautionary principle approach in assessing the potential environmental, human health, and socioeconomic risks of GMOs. There have been a number of measures taken to facilitate national capacity building, including financial support and the establishment of the Biosafety Clearing-House, an online database for international information exchange.

Conflicts and Obstacles

Nevertheless, there are numerous obstacles to the implementation of the CBD and the Cartagena Protocol. Primarily, efforts at strengthening national mechanisms for biodiversity protection have come into conflict with the World Trade Organization (WTO) over the regulation of biotechnology. The WTO, adopting U.S. regulatory views on the safety of genetically modified products, has focused on opening international markets and protecting intellectual property rights for biotech corporations. In contrast, the Cartagena Protocol establishes a framework for countries to adopt stricter scientific criteria for determining acceptable risk, allowing the refusal of genetically modified products until their safety can be proven. In this sense, the protocol acts as a counterweight to the WTO by augmenting the bargaining power of developing countries. This conflict is evident in a recent $38.4 million biosafety project carried out in 123 countries to fulfill the requirements of the Cartagena Protocol. Sponsored by the United Nations Environmental Program (UNEP) and the Global Environmental Facility (GEF), the goals are to create national legislative and decisionmaking systems for biotechnology regulation.

...

  • Loading...
locked icon

Sign in to access this content

Get a 30 day FREE TRIAL

  • Watch videos from a variety of sources bringing classroom topics to life
  • Read modern, diverse business cases
  • Explore hundreds of books and reference titles

Sage Recommends

We found other relevant content for you on other Sage platforms.

Loading